These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 24369278

  • 21. [Effect and role of teriparatide in the treatment of osteoporosis].
    Nakamura T.
    Clin Calcium; 2012 Mar; 22(3):309-14. PubMed ID: 22370296
    [Abstract] [Full Text] [Related]

  • 22. [Treatment with recombinant parathyroid hormone of advanced osteoporosis--series of cases].
    Skiba K, Adamczak M, Wiecek A.
    Przegl Lek; 2011 Mar; 68(7):391-5. PubMed ID: 22010479
    [Abstract] [Full Text] [Related]

  • 23. The role of teriparatide in sequential and combination therapy of osteoporosis.
    Meier C, Lamy O, Krieg MA, Mellinghoff HU, Felder M, Ferrari S, Rizzoli R.
    Swiss Med Wkly; 2014 Mar; 144():w13952. PubMed ID: 24896070
    [Abstract] [Full Text] [Related]

  • 24. Safety and effectiveness of daily teriparatide for osteoporosis in patients with severe stages of chronic kidney disease: post hoc analysis of a postmarketing observational study.
    Nishikawa A, Yoshiki F, Taketsuna M, Kajimoto K, Enomoto H.
    Clin Interv Aging; 2016 Mar; 11():1653-1659. PubMed ID: 27895472
    [Abstract] [Full Text] [Related]

  • 25. The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis.
    Orwoll ES, Scheele WH, Paul S, Adami S, Syversen U, Diez-Perez A, Kaufman JM, Clancy AD, Gaich GA.
    J Bone Miner Res; 2003 Jan; 18(1):9-17. PubMed ID: 12510800
    [Abstract] [Full Text] [Related]

  • 26. Anabolic therapies for osteoporosis.
    Uihlein AV, Leder BZ.
    Endocrinol Metab Clin North Am; 2012 Sep; 41(3):507-25. PubMed ID: 22877427
    [Abstract] [Full Text] [Related]

  • 27. Safety and effectiveness of daily teriparatide in a prospective observational study in patients with osteoporosis at high risk of fracture in Japan: final report.
    Nishikawa A, Ishida T, Taketsuna M, Yoshiki F, Enomoto H.
    Clin Interv Aging; 2016 Sep; 11():913-25. PubMed ID: 27462147
    [Abstract] [Full Text] [Related]

  • 28. Indications to teriparatide treatment in patients with osteoporosis.
    Rizzoli R, Kraenzlin M, Krieg MA, Mellinghoff HU, Lamy O, Lippuner K.
    Swiss Med Wkly; 2011 Sep; 141():w13297. PubMed ID: 22057669
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Update and perspectives of anabolic therapies for osteoporosis].
    Endo I, Matsumoto T.
    Clin Calcium; 2012 Mar; 22(3):327-33. PubMed ID: 22370299
    [Abstract] [Full Text] [Related]

  • 32. [Teriparatide: an anabolic drug for the treatment of patients with osteoporosis].
    Lems WF, Hamdy NA, Netelenbos JC.
    Ned Tijdschr Geneeskd; 2006 Jan 21; 150(3):132-7. PubMed ID: 16463613
    [Abstract] [Full Text] [Related]

  • 33. Teriparatide in the treatment of osteoporosis.
    Stroup J, Kane MP, Abu-Baker AM.
    Am J Health Syst Pharm; 2008 Mar 15; 65(6):532-9. PubMed ID: 18319498
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Bone-forming agents in the management of osteoporosis.
    Neuprez A, Reginster JY.
    Best Pract Res Clin Endocrinol Metab; 2008 Oct 15; 22(5):869-83. PubMed ID: 19028361
    [Abstract] [Full Text] [Related]

  • 37. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
    Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH.
    N Engl J Med; 2001 May 10; 344(19):1434-41. PubMed ID: 11346808
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Teriparatide (rhPTH 1-34) for the treatment of osteoporosis.
    Ebeling PR, Russell RG.
    Int J Clin Pract; 2003 Oct 10; 57(8):710-8. PubMed ID: 14627183
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.